Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
Bruker Corp (BRKR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Orbis Investment Management William B. Gray | 17,940,076 | $1,079,633,773 | 3.71% | |
| 2. | Sculptor Capital Daniel S. Och | 4,625,000 | $278,332,500 | +42% | 2.27% |
| 3. | Aequim Alternative Investments Franklin Parlamis | 580,000 | $258,757,314 | +16% | 4.02% |
| 4. | Sachem Head Capital Scott Ferguson | 2,915,000 | $175,424,700 | 3.64% | |
| 5. | AQR Capital Management Cliff Asness | 2,512,706 | $149,493,466 | +95% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.36 | 2,608 | $100,042.88 | 38,462,171 | 2025-06-06 | Filing | |
| $47.40 | 500 | $23,697.50 | 3,472 | 2025-03-10 | Filing | |
| $51.23 | 6,937 | $355,382.51 | 38,459,563 | 2025-02-18 | Filing | |
| $50.75 | 13,063 | $662,947.25 | 38,452,626 | 2025-02-18 | Filing | |
| $51.36 | 3,583 | $184,022.88 | 38,439,563 | 2024-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.90 | 3,473 | $197,613.70 | 9,801 | 2026-08-17 | Filing | |
| $57.60 | 2,000 | $115,200.00 | 123,347 | 2026-08-14 | Filing | |
| $60.25 | 2,000 | $120,500.00 | 128,443 | 2026-07-15 | Filing | |
| $54.76 | 2,000 | $109,520.00 | 128,443 | 2026-06-15 | Filing | |
| $43.90 | 2,000 | $87,800.00 | 128,443 | 2026-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,237,425 | $1,217,888,223 | 0.05% | |
| 2. | 11,407,332 | $686,493,262 | 0.01% | |
| 3. | 9,483,978 | $570,745,799 | 17.56% | |
| 4. | 4,888,290 | $294,177,292 | 0.01% | |
| 5. | 4,859,252 | $292,429,785 | 0.01% |
News See All
10 Best Brain-Computer Interface Stocks to Buy
On May 10, Bloomberg reported that brain-computer interfaces are transitioning from experimental to early implementation, allowing users to control computers, robotic arms, and communication tools with...
Is Bruker Corporation (BRKR) A Good Stock To Buy Now?
Is BRKR a good stock to buy? We came across a bullish thesis on Bruker Corporation on X.com by @BryzonX. In this article, we will summarize the bulls’ thesis on BRKR.
Bruker Corporation (NASDAQ:BRKR) Q1 2026 Earnings Call Transcript
Operator: Good day, and welcome to the Bruker Corporation First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Here’s Why Bruker’s (BRKR) Positive Momentum Returned in Q4
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Will Bruker (BRKR) be Able to Rebound?
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here.
Reasons Why Bruker Corporation (BRKR) Appears So Attractive
On February 13, Jefferies analyst Tycho Peterson reduced the firm’s price target on Bruker Corporation (NASDAQ:BRKR) from $55 to $50.
10 Best Life Sciences Stocks to Buy According to Hedge Funds
Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.
Bruker Corporation (NASDAQ:BRKR) Q4 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Bruker Corporation Fourth Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
Guggenheim Raises Price Target for Bruker Corporation (BRKR)
On January 26, Guggenheim analyst Subbu Nambi reiterated her Buy rating on Bruker Corporation (NASDAQ:BRKR).
Hedge Fund Resource Center